add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
A/H1N1 flu activity easing in CanadaXinhua - - 1 hour ago OTTAWA, Dec. 2 (Xinhua) -- The A/H1N1 flu is waning in Canada, with fewer hospital admissions and fewer reported cases in schools, health officials said Wednesday. 13 new stem cell lines approved for researchUSA Today - - 2 hours ago By Stem Cell Program, Children's Hospital Boston By Dan Vergano, USA TODAY Health officials Wednesday gave the green light to federally funded research on 13 human embryonic stem cell lines, the first approved since the Bush administration imposed ... NIH Has Approved 13 Human Stem Cell Lines For Research Wall Street Journal HIV Tests Turn Blood Into Cash in ChinaNew York Times - - 1 hour ago Patrons of the Purple Tribe nightclub in Tianjin, China, can earn money for taking an HIV test, part of a Gates Foundation initiative that has drawn criticism. World AIDS Day honored with vigil downtown UM Maneater US debate over mammograms splits along party linesReuters - - 1 hour ago WASHINGTON, Dec 2 (Reuters) - Republicans argued on Wednesday that recommendations advising against routine mammograms for women in their 40s could be used to ration healthcare under reform legislation before Congress, a charge Democrats denied.
The Associated Press
Video:
Task Force Says It Poorly Communicated Breast Cancer Guidelines
The Associated Press
Senators Pitch to Women and Elderly on Health BillNew York Times - - Dec 1, 2009 WASHINGTON - In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies on Tuesday, with Democrats seeking additional medical benefits for women and ... Tempers flare as Senate debates health care The Associated Press A subsidy for those most in needWashington Post - - 1 hour ago Unless Congress and the president act soon, many unemployed workers and their dependents may lose their health insurance if a federal subsidy to help them pay for the coverage isn't extended. Health insurance subsidy for the jobless to end soon San Jose Mercury News Obesity Rise Trumps Smoking DeclineWebMD - - 4 hours ago Dec. 2, 2009 -- Over the next decade the health benefits achieved because fewer Americans are smoking will be more than overshadowed by the negative health effects of the unchecked rise in obesity, new research suggests. Obesity's rise trumps smoking's decline when it comes to life expectancy Los Angeles Times Drug-resistant swine flu reported in Va. and Md.Washington Post - - 5 hours ago Two swine flu patients in Maryland and one in Virginia were hospitalized with a form of the virus resistant to a commonly used medicine, prompting infectious disease specialists to call for renewed caution even as the intensity of the ... Squeezing Money Out of Home Health CareNew York Times - 2 hours ago By THE EDITORS James Estrin/The New York Times Home health care aides have become lifelines for many elderly people. Under the health care bills currently being debated in Congress, more than 30 million uninsured Americans would gain coverage. MARK STRAIN: Reforming healthcare or more bloat? Naples Daily News New Web site focuses on long-term care data McKnight's Long Term Care News Ohio charity workers find marijuana in donated jugThe Associated Press - 3 hours ago MARIETTA, Ohio - Police said whoever donated a water jug to a charity in southeast Ohio probably didn't mean to be so generous. Sanofi Warning on Antidepressant NorpraminABC News - 6 hours ago WASHINGTON (Reuters) - French drugmaker Sanofi-Aventis SA has warned that its antidepressant Norpramin should be given with extreme caution to patients with a history of certain heart problems, the US Food and Drug Administration said on Wednesday. Desipramine Warnings Expanded MedPage Today Study: Childhood lead exposure causes permanent brain damageUSA Today - 2 hours ago By Robert Priedt, HealthDay "What we have found is that no region of the brain is spared from lead exposure. Distinct areas of the brain are affected differently," study author Kim Cecil, an imaging scientist at Cincinnati Children's Hospital Medical ... Lead Exposure in Children Linked to Permanent Brain Damage: Study AboutLawsuits.com Study shows treatment after heart attack is getting fasterUSA Today - - 2 hours ago A national push to avert delays in heart attack treatment has sharply increased the percentage of people who get prompt care, a study shows. Heart Attack Treatment Speeds Up Nationwide U.S. News & World Report Heart attack patients getting faster treatment Boston Globe Dyax gets FDA approval for genetic disorder drugThe Associated Press - Dec 1, 2009 SAN FRANCISCO - Biotherapeutic drug company Dyax Corp. said Tuesday it received Food and Drug Administration approval to market Kalbitor for treatment of the genetic disorder hereditary angioedema in patients 16 years and up. Dyax investors bid up shares on fda's Kalbitor approvalFierceBiotech - - 11 hours ago Dyax shares rocketed up 38 percent yesterday evening after the developer announced that the FDA had approved its lead drug Kalbitor (also known as ecallantide or DX-88) for patients with hereditary angioedema, a rare and often lethal genetic disease ... Dyax gets FDA marketing nod on genetic disease drugForbes - Dec 1, 2009 Dec 1 (Reuters) - Dyax Corp ( DYAX - news - people ) said it received approval from the US health regulator to market its drug that treats a rare genetic disease, sending its shares up 36 percent in trading after the bell. FDA Okays First Subcutaneous HAE DrugMedPage Today - - 9 hours ago WASHINGTON -- The FDA has approved ecallantide (Kalbitor), the first subcutaneous treatment for acute hereditary angioedema (HAE) attacks, for patients 16 and older. Dyax shares rocket on FDA clearance for Kalbitor The Associated Press Kalbitor approved for acute attacks of hereditary angioedema (HAE)Monthly Prescribing Reference - 11 hours ago Kalbitor (ecallantide for injection, from Dyax) has been approved by the FDA for the treatment of acute attacks of hereditary angioedema (HAE) in patients ≥16 years of age. Dyax Shares Rocket as FDA Clears Treatment for Rare Inflammatory DiseaseXconomy - - Dec 1, 2009 Dyax got some good news late today that sent shares booming. The Cambridge, MA-based company (NASDAQ: DYAX) said it has received FDA clearance to start selling a drug that treats hereditary angioedema, a rare genetic condition in which people get rapid ... FDA oks Dyax Drug For Rare Swelling Disorder; Stock Soars>DYAXWall Street Journal - Dec 1, 2009 Dyax Corp. (DYAX) said the Food and Drug Administration approved its drug to treat a rare swelling disorder known as hereditary angioedema in patients age 16 and older. | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
